TransDigm (TDG) PT Raised to $1,839 at UBS

UBS analyst Gavin Parsons raised the price target on TransDigm (NYSE: TDG) to $1,839.00 (from $1,815.00) while maintaining a Buy rating.

The analyst commented, "We revise our 12-month price target to $1,839 from $1,815, on 22.3X EV/EBITDA, now target 1SD premium (from 1.5SD previously) to reflect multiple periods of slower-than-peer aftermarket growth. We revise our FY25E-FY29E EBITDA as defined to $4,776/5,294/5,871/6,447/6,993mn from $4,774/5,299/5,828/6,407/6,942mn."

You May Also Be Interested In

• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
• Riskified Ltd. (RSKD) PT Raised to $5.50 at Goldman Sachs
• Ford To Move Production Of Some Lincoln Models From China To U.S. - Reuters